These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1981890)

  • 1. High-performance liquid chromatographic assay of dilevalol, a beta-adrenoceptor blocker, in rat and human plasma.
    Dionisotti S; Bamonte F; Monopoli A
    J Chromatogr; 1990 Sep; 530(2):458-62. PubMed ID: 1981890
    [No Abstract]   [Full Text] [Related]  

  • 2. High-performance liquid chromatographic assay for dilevalol in human plasma and urine using a PRP-1 column and fluorimetric detection.
    Alton KB; Petruzzi RF; Patrick JE
    J Chromatogr; 1988 Mar; 425(2):363-72. PubMed ID: 2897376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic method for the determination of labetalol in plasma using ultraviolet detection.
    Hidalgo IJ; Muir KT
    J Chromatogr; 1984 Jan; 305(1):222-7. PubMed ID: 6707148
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimization of fluorescence detection for the determination of labetalol in plasma by high-performance liquid chromatography.
    Ostrovská V; Svobodová X; Pechová A; Kusala S; Svoboda M
    J Chromatogr; 1988 Jul; 446():323-7. PubMed ID: 3209660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatography of deacetylmetipranolol in plasma.
    Tkaczyková M; Safarík L
    J Pharm Biomed Anal; 1989; 7(12):1805-10. PubMed ID: 2577449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of dilevalol in breast milk.
    Radwanski E; Nagabhushan N; Affrime MB; Perentesis G; Symchowicz S; Patrick JE
    J Clin Pharmacol; 1988 May; 28(5):448-53. PubMed ID: 2899094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic assay for labetalol in human plasma using a PRP-1 column and fluorometric detection.
    Alton KB; Leitz F; Bariletto S; Jaworsky L; Desrivieres D; Patrick J
    J Chromatogr; 1984 Nov; 311(2):319-28. PubMed ID: 6520179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
    Tham TC; McKaigue JP; Guy S; Shanks RG; Riddell JG
    Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of dilevalol (III). A pharmacokinetic study of dilevalol in elderly subjects with essential hypertension.
    Fujimura A; Sugimoto K; Kumagai Y; Nakashima H; Ebihara A
    J Clin Pharmacol; 1989 Nov; 29(11):1008-12. PubMed ID: 2574727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive chiral high-performance liquid chromatographic assay for labetalol in biological fluids.
    Dakers JM; Boulton DW; Fawcett JP
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):215-20. PubMed ID: 9518153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Column liquid chromatographic measurement of betaxolol in plasma or serum.
    Bhamra RK; Ward AE; Holt DW
    J Chromatogr; 1987 Jun; 417(1):229-32. PubMed ID: 2887581
    [No Abstract]   [Full Text] [Related]  

  • 12. Automated sample preparation on-line with thermospray high-performance liquid chromatography-mass spectrometry for the determination of drugs in plasma.
    Lant MS; Oxford J; Martin LE
    J Chromatogr; 1987 May; 394(1):223-30. PubMed ID: 3597620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of dilevalol and its conjugates in man. Assay method for plasma, blood, urine and bile samples and preliminary pharmacokinetic studies.
    Neubeck M; Becker C; Henke D; Rösch W; Spahn-Langguth H; Mutschler E
    Arzneimittelforschung; 1993 Sep; 43(9):953-7. PubMed ID: 8240457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated HPLC method for quantitative determination of talinolol in rat plasma and application to a preclinical pharmacokinetic study.
    Pathak SM; Musmade PB; Bhat KM; Udupa N
    Bioanalysis; 2010 Jan; 2(1):95-104. PubMed ID: 21083123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of the enantiomers of esmolol and its acid metabolite in human plasma by reversed phase liquid chromatography with solid-phase extraction.
    Tang YH; He Y; Yao TW; Zeng S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):249-54. PubMed ID: 15135097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxicologic analysis of some adrenergic-beta blockers in the diagnosis of intoxications].
    Wachowiak R; Tezyk A
    Arch Med Sadowej Kryminol; 2003; 53(4):289-99. PubMed ID: 14971294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration.
    Gianesello V; Brenn E; Figini G; Gazzaniga A
    J Chromatogr; 1989 Jul; 473(2):343-52. PubMed ID: 2570078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
    Riva E; Mennini T; Latini R
    Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.
    Walley T; Tsao Y; Scott A; Mackay E; Vandenburg M; Breckenridge A
    Br J Clin Pharmacol; 1993 Jun; 35(6):623-8. PubMed ID: 8329290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internally standardized simultaneous assay of propafenone and 5-hydroxypropafenone enantiomers in human plasma by means of high performance liquid chromatography.
    Kern R
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):203-10. PubMed ID: 7913980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.